Apellis Pharmaceuticals Inc (APLS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

6400 WESTWIND WAY CRESTWOOD, KY 40014

Apellis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. Apellis Pharmaceuticals serves clients worldwide.

Data based on most recent fiscal year report
Market Cap1.091 Billion Shares Outstanding50.33 Million Avg Volume77.406 Thousand
1-Yr BETA vs S&P TR2.027 Current Ratio27.79 Quick Ratio27.79
View SEC Filings from APLS instead.
Q2 2019 All Institutions Hedge Funds 1
To trade APLS now:
Filers who had this stock in their top 10: 3 1 (0.1%)
13F Filers holding this stock: 97 17 (1.76%)
Aggregate 13F shares on 06/30/2019: 40.409 Million 10.16 Million
Aggregate 13F shares on 03/31/2019: 40.126 Million 11.077 Million
Percent change: 0.71% -8.29%
Funds creating new positions: 21 2
Funds Adding to an existing position: 44 9
Funds closing out their position: 13 7
Funds reducing their position: 20 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding APLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

11.7 Thousand total shares from 1 transactions

Open Market Sells (S)

74 Thousand total shares from 10 transactions

Exercise Derivative Conversion (M)

37.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FRANCOIS CEDRIC CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,251,204 2019-10-15 6

MACHIELS ALEC

  • Director
6,352 2019-10-01 1

DESCHATELETS PASCAL CHIEF OPERATING OFFICER

  • Officer
881,743 2019-09-25 3

SULLIVAN TIMOTHY EUGENE CHIEF FINANCIAL OFFICER

  • Officer
11,699 2019-08-29 2

WATSON DAVID O. GENERAL COUNSEL

  • Officer
32,042 2019-08-07 2

CELONA LUCIA SEE REMARKS

  • Officer
0 2019-08-05 1

TOWNSEND ADAM J. SEE REMARKS

  • Officer
0 2019-04-08 1

LACKNER THOMAS A. SEE REMARKS

  • Officer
5,000 2019-04-08 1

SADR AHMAD SEE REMARKS

  • Officer
0 2019-04-08 1

MORNINGSIDE VENTURE INVESTMENTS LTD

  • 10% Owner
12,015,802 2019-03-11 1

PERRY NICOLE D VICE PRESIDENT - FINANCE

  • Officer
0 2019-02-08 1

GROSSI FEDERICO SEE REMARKS

  • Officer
0 2019-02-08 2

SCHEIBLER LUKAS SEE REMARKS

  • Officer
0 2019-02-08 1

CHAN GERALD

  • Director
0 2019-01-01 1

DUNLOP A. SINCLAIR

  • Director
0 2019-01-01 1

O'BRIEN STEPHANIE MONAGHAN

  • Director
0 2019-01-01 1

AXON STEVEN CHIEF BUSINESS OFFICER

  • Officer
50,110 2018-11-14 1

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
No longer subject to file 2018-10-31 0

CORMORANT ASSET MANAGEMENT, LP

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND I, LP

CHEN BIHUA

  • Director
  • 10% Owner
0 2018-10-30 0

VENBIO GLOBAL STRATEGIC FUND II L.P.

  • 10% Owner
No longer subject to file 2018-01-25 0

HILLHOUSE CAPITAL MANAGEMENT, LTD.

  • 10% Owner
71,139,367 2018-01-22 0

AJU IB INVESTMENT CO., LTD.

  • 10% Owner
No longer subject to file 2017-11-13 0

GELLERT MICHAEL E

  • 10% Owner
No longer subject to file 2017-11-13 0

POTENTIA HOLDINGS, LLC

  • 10% Owner
3,826,601 2017-11-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

2019-10-15 S 1,476 $25.59 d 1,020,317 1,251,204.00 direct yes

FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

2019-10-15 S 3,524 $26.61 d 1,016,793 1,251,204.00 direct yes

DESCHATELETS PASCAL - Officer CHIEF OPERATING OFFICER

2019-09-25 S 1,010 $25.64 d 881,743 881,743.00 direct yes

DESCHATELETS PASCAL - Officer CHIEF OPERATING OFFICER

2019-09-25 S 20,531 $25.24 d 882,753 881,743.00 direct yes

DESCHATELETS PASCAL - Officer CHIEF OPERATING OFFICER

2019-09-24 S 1,295 $24.96 d 903,284 903,284.00 direct yes

DESCHATELETS PASCAL - Officer CHIEF OPERATING OFFICER

2019-09-24 S 20,307 $24.56 d 904,579 903,284.00 direct yes

DESCHATELETS PASCAL - Officer CHIEF OPERATING OFFICER

2019-09-23 S 20,758 $25.07 d 924,986 903,284.00 direct yes

DESCHATELETS PASCAL - Officer CHIEF OPERATING OFFICER

2019-09-23 S 100 $25.53 d 924,886 903,284.00 direct yes

FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

2019-09-16 S 260 $27.17 d 1,021,793 1,256,204.00 direct yes

FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

2019-09-16 S 4,740 $26.56 d 1,022,053 1,256,204.00 direct yes

SULLIVAN TIMOTHY EUGENE - Officer CHIEF FINANCIAL OFFICER

2019-08-29 P 11,699 $29.71 a 11,699 11,699.00 direct

FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-23 M 37,505 $2.67 a 1,026,793 1,261,204.00 direct

FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-23 M 37,505 d 478,200 1,261,204.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments